PX1 Research supplies USA-manufactured, high-purity Semax liquid drop preparations strictly for in vitro and laboratory research applications. Every lot undergoes rigorous third-party analytical testing, including RP-HPLC purity assay and mass spectrometry verification, to ensure exact chemical identity and consistency across neurobiological assays.
PX1 Research supplies USA-manufactured, high-purity Semax liquid drop preparations strictly for in vitro and laboratory research applications. Every lot undergoes rigorous third-party analytical testing, including RP-HPLC purity assay and mass spectrometry verification, to ensure exact chemical identity and consistency across neurobiological assays.
Sourcing high-purity semax drops for sale requires verifying that the supplier provides fully characterized, reagent-grade peptide solutions certified by independent analytical testing. Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH 4-10) sequence, stabilized with a C-terminal Pro-Gly-Pro tripeptide. When acquired for laboratory use, liquid drop formulations allow precise volumetric administration in preclinical experimental setups.
To maintain valid experimental controls, researchers must ensure that liquid drop preparations are free of non-disclosed preservatives, heavy metals, or microbial contaminants. PX1 Research offers laboratory-grade Semax solution preparations synthesized in USA-based, GMP-compliant facilities. Each batch is paired with a lot-specific Certificate of Analysis (COA) detailing purity, mass identification, and endotoxin levels to safeguard test validity.
Semax is a synthetic peptide fragment with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was engineered to extend the biological half-life and enzymatic stability of the native ACTH(4-10) fragment. The addition of the C-terminal Pro-Gly-Pro sequence provides resistance against vascular and cellular carboxypeptidases and aminopeptidases, which rapidly degrade unmodified neuropeptides in biological matrices.
In cell culture and animal models, this structural modification enables prolonged interactions with central targets without displaying the hormonal or steroidogenic activities associated with full-length adrenocorticotropic hormone. Investigational formulations of Semax for research use are typically dissolved in buffered, isotonic liquid bases to evaluate localized enzymatic resistance, mucosal permeability in vitro, and central receptor binding dynamics.
The primary mechanism of action documented in preclinical literature involves the up-regulation of neurotrophic factors, particularly Brain-Derived Neurotrophic Factor (BDNF) and its cognate receptor, Tropomyosin receptor kinase B (TrkB). In vitro neuronal cultures treated with Semax demonstrate rapid mRNA upregulation of BDNF and Nerve Growth Factor (NGF) in hippocampal and cortical cellular populations.
Preclinical rodent models suggest that Semax administration leads to a sustained increase in BDNF expression within central tissues, promoting dendritic branching, synaptic plasticity, and neuronal survival under hypoxic or excitotoxic conditions. Furthermore, research indicates that Semax modulates melanocortin receptor activity (MC4R and MC5R), influencing neuroinflammatory cascades, microglial activation, and cerebrovascular hemodynamics. Review our comprehensive neurotrophic pathways database for detailed molecular pathways.
Preclinical investigations using rodent models of focal cerebral ischemia have shown that early administration of Semax reduces infarction volume and suppresses pro-inflammatory cytokine activity (including IL-1β, IL-6, and TNF-α). These studies highlight the peptide's ability to preserve cellular integrity during ischemic stress by altering gene expression patterns involved in apoptosis and inflammatory signaling.
In behavioral paradigms evaluating spatial memory, passive avoidance, and conditional learning, Semax-treated animal models exhibited accelerated task acquisition and resistance to scopolamine-induced cognitive deficits. In vitro assays further demonstrate that Semax influences monoaminergic transmission, temporarily elevating dopamine and serotonin metabolite levels in rat striatal tissues. These multi-target effects make Semax a critical reference compound in preclinical neuroscience research.
When designing neurobiological trials, investigators frequently compare Semax against other synthetic regulatory peptides to evaluate differential signaling mechanisms, stability profiles, and target affinities within central tissue models.
A primary comparator is Selank solution, a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide Tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). While Semax acts primarily via BDNF expression and melanocortin receptor modulation, Selank influences GABAergic neurotransmission and enkephalin stability. Another key derivative is N-Acetyl Semax Amidate, an acetylated and amidated variant designed for altered lipophilicity and resistance to enzymatic cleavage. Additionally, investigators studying broader cellular longevity and neuroprotective mechanisms often cross-reference these peptides with Epithalon research models to compare gene expression pathways involved in tissue preservation.
Standard laboratory protocols for Semax drops involve handling the liquid formulation under sterile laminar flow hoods to prevent microbial contamination. Liquid drop formulations are typically calibrated to deliver a precise volume per drop (e.g., 0.05 mL per drop), allowing researchers to accurately calculate molar concentrations for in vitro assays or preclinical model administration.
When diluting or transferring Semax solutions, researchers should use sterile, micro-filtered pipette tips and low-protein-binding microcentrifuge tubes to avoid non-specific binding of the peptide to plastic surfaces. If reconstitution of lyophilized material into drop form is required, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) should be utilized to maintain molecular stability and physiological osmolarity.
Peptide integrity is highly sensitive to environmental factors including temperature, pH, light exposure, and mechanical agitation. Liquid Semax drop preparations should be stored under refrigerated conditions (2°C to 8°C) for short-term experimental series, or frozen at -20°C to -80°C for long-term storage to prevent peptide bond hydrolysis.
Degradation of Semax primarily occurs through oxidation of the N-terminal methionine residue or cleavage of proline-containing peptide bonds by specific endopeptidases if exposed to unsterilized aqueous environments. Repeated freeze-thaw cycles must be avoided, as ice crystal formation can induce physical shear stress, denaturing the peptide chains. For optimal reproducibility across experimental batches, refer to our complete catalog of research peptides for standardized storage and handling documentation.
To ensure that observed experimental outcomes are attributable solely to the target sequence, research peptides must undergo rigorous analytical verification before deployment in laboratory assays. PX1 Research subjects every batch of Semax drops to a comprehensive battery of quality control tests.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to verify chemical purity, ensuring a minimum threshold of ≥99.0% purity with zero non-disclosed organic impurities. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the exact molecular weight (810.9 g/mol for Semax free base). Furthermore, Limulus Amebocyte Lysate (LAL) testing measures bacterial endotoxin levels, guaranteeing concentrations well below standard research limits (<0.1 EU/mg) to prevent confounding immune responses in cell cultures.
Selecting a reliable supplier for research-grade peptides requires thorough evaluation of manufacturing standards, transparency, and documentation practices. Low-quality suppliers often offer unverified compounds lacking lot-specific testing, introducing variables that compromise scientific rigor.
PX1 Research operates exclusively within USA-manufactured, ISO 17025-accredited and GMP-compliant facilities. Every product listing is backed by an accessible, lot-specific COA that includes raw HPLC chromatograms and mass spectra. This commitment to full lot traceability ensures that academic institutions, biotechnology companies, and contract research organizations (CROs) receive stable, predictable reagents for advanced study. Institutional buyers can apply for bulk laboratory accounts to secure consistent lot reserves.
When purchasing Semax liquid drop formulations for laboratory investigation, PX1 Research provides the quality assurance required for precise experimental design. All orders are processed, packaged under cleanroom conditions, and dispatched with speed to preserve temperature integrity.
PX1 Research ships directly from facilities located in California and Arizona, offering same-day shipping for orders placed Monday through Friday before 3:00 PM EST. Our dedicated technical support team is available to assist qualified researchers with analytical verification documentation, solution characteristics, and bulk lot procurement.
What is the primary specification for Semax drops supplied by PX1 Research?
Semax drops supplied by PX1 Research are formulated as liquid preparations certified at ≥99.0% purity as determined by RP-HPLC. The product is manufactured in the USA strictly for laboratory and in vitro research use only.
How is the chemical identity of Semax drops verified?
Chemical identity is verified using Liquid Chromatography-Mass Spectrometry (LC-MS) or MALDI-TOF mass spectrometry to confirm the theoretical molecular weight of 810.9 g/mol, alongside RP-HPLC to confirm sequence purity.
What are the recommended storage conditions for Semax liquid drop formulations?
Liquid Semax drop formulations should be stored refrigerated at 2°C to 8°C for immediate research use. For long-term storage, unopened vials should be kept frozen at -20°C or colder to prevent peptide hydrolysis.
Are PX1 Research Semax drops tested for bacterial endotoxins?
Yes. Every lot of Semax undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly under <0.1 EU/mg, preventing endotoxin-induced artifacts in cell culture and animal models.
How does Semax compare to N-Acetyl Semax Amidate in laboratory trials?
Semax is the original heptapeptide sequence (Met-Glu-His-Phe-Pro-Gly-Pro), whereas N-Acetyl Semax Amidate features N-terminal acetylation and C-terminal amidation. These synthetic modifications alter enzymatic resistance, half-life, and lipophilicity in preclinical models.
Can Semax drops be diluted for in vitro cell culture assays?
Yes, researchers can dilute Semax liquid drops into appropriate sterile cell culture media or phosphate-buffered saline (PBS, pH 7.4) under aseptic conditions using sterile micro-pipettes.
Does PX1 Research provide a Certificate of Analysis (COA) with Semax orders?
Yes, every batch of Semax drops includes a lot-specific Certificate of Analysis detailing HPLC purity chromatograms, mass spectrometry verification, and endotoxin assay results.
Where does PX1 Research ship Semax drop orders from?
PX1 Research ships all research peptides directly from USA-based facilities in California and Arizona, offering same-day dispatch for orders placed before 3:00 PM EST, Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.